Miv Therapeutics, Inc. (IVT) Misses Q3 EPS by 2c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of ($0.01), $0.02 worse than the analyst estimate of $0.01.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
• XP Inc. (XP) Tops Q2 EPS by 8c
• Tesla to launch Cybercab in Austin this month - report